-transparent.png){kind=logo}
We report the synthesis of receptor antagonists of neuropeptide Y (NPY) by a strategy based on synthesis of mixtures of analogs and the subsequent isolation and identification of receptor antagonists from these mixtures. After screening a series of mixtures of NPY analogs by using an NPY antagonist assay, two potent receptor antagonists, designated PYX-1 and PYX-2, were isolated from an antagonist-containing mixture. Structural analysis revealed these analogs to be Ac-[3-(2,6-dichlorobenzyl)Tyr27, D-Thr32]NPY-(27-36) amide and Ac-[3-(2,6-dichlorobenzyl)Tyr27,36,D-Thr32]NPY-(27-36) amide, respectively. The receptor antagonists inhibited release of intracellular calcium elicited by NPY in human erythroleukemia cells and displaced 3H-labeled NPY from NPY receptors in rat brain membrane. The approach of screening and identifying useful analogs from synthetic mixtures may significantly reduce the time and resources previously required for development of receptor antagonists.
K Tatemoto, and
M J Mann, and
M Shimizu
August 2001,
IDrugs : the investigational drugs journal,
K Tatemoto, and
M J Mann, and
M Shimizu
February 2002,
Bioorganic & medicinal chemistry letters,
K Tatemoto, and
M J Mann, and
M Shimizu
September 1995,
Proceedings of the National Academy of Sciences of the United States of America,
K Tatemoto, and
M J Mann, and
M Shimizu
December 1997,
Expert opinion on investigational drugs,
K Tatemoto, and
M J Mann, and
M Shimizu
September 1996,
Trends in pharmacological sciences,
K Tatemoto, and
M J Mann, and
M Shimizu
June 2012,
Bioorganic & medicinal chemistry letters,
K Tatemoto, and
M J Mann, and
M Shimizu
March 2004,
Bioorganic & medicinal chemistry letters,
K Tatemoto, and
M J Mann, and
M Shimizu
January 2004,
Progress in medicinal chemistry,
K Tatemoto, and
M J Mann, and
M Shimizu
January 1997,
Peptides,
K Tatemoto, and
M J Mann, and
M Shimizu
July 2003,
Peptides,
